Clinical Trial Update: 5-azacytidine Treatment Versus 5-azacytidine Followed by Allogeneic Stem Cell Transplantation in Elderly Patients With Myelodysplastic Syndrome (MDS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing 5-azacytidine alone versus 5-azacytidine followed by allogeneic stem cell transplantation in elderly patients with myelodysplas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome
• Myelomonocytic Leukemia

Drugs mentioned

• 5-Azacytidine (5-azacytidine)

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia | Phase 2 | Status: COMPLETED